Grassi Investment Management’s Medtronic MDT Stock Holding History

Grassi Investment Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-86,325	Closed	-$6.97M	–	126
2022 Q3	$6.97M	Hold	86,325	–	–	1.02%	40
2022 Q2	$7.75M	Sell	86,325 -300	-0.3%	-$30.4K	1.02%	40
2022 Q1	$9.61M	Sell	86,625 -26,175	-23%	-$2.77M	1%	36
2021 Q4	$11.7M	Sell	112,800 -150	-0.1%	-$17.4K	1.17%	30
2021 Q3	$14.2M	Buy	112,950 +975	+0.9%	+$126K	1.59%	15
2021 Q2	$13.9M	Buy	111,975 +150	+0.1%	+$18.8K	1.51%	20
2021 Q1	$13.2M	Buy	111,825 +75	+0.1%	+$8.79K	1.5%	20
2020 Q4	$13.1M	Sell	111,750 -2,685	-2%	-$296K	1.66%	17
2020 Q3	$11.9M	Buy	114,435 +27,490	+32%	+$2.76M	1.69%	16
2020 Q2	$7.97M	Buy	+86,945	New	+$8.34M	1.15%	37

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Grassi Investment Management's MDT Position: Q4 2022 in Review

Grassi Investment Management sold out of Medtronic (MDT) in Q4 2022, closing a stake of 86,325 shares — an estimated $6.97M sold.

Grassi Investment Management first reported a position in MDT in Q2 2020 and held it in 10 quarters. The position peaked at $14.2M in Q3 2021. 1,962 funds tracked by Wall St. Rank hold MDT as of Q4 2022.

Grassi Investment Management reported no remaining Medtronic position as of Q4 2022 after selling out during the quarter.
Grassi Investment Management sold 86,325 Medtronic shares in Q4 2022, an estimated $6.97M.
Grassi Investment Management first reported a position in Medtronic in Q2 2020 and held it in 10 quarters.
Grassi Investment Management's Medtronic position peaked at $14.2M in Q3 2021.
1,962 funds tracked by Wall St. Rank held Medtronic as of Q4 2022.

Based on Grassi Investment Management's 13F filing for Q4 2022, filed 10 Jan 2023.